CN-16

N/A

Report date: 2025/02/08 12:49:57

Base Information

Drug NameCN-16
Drug Alias NameCN-16
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionLipopolysaccharide (LPS) inhibitors
TargetsLipopolysaccharide (LPS)
Therapy Area/IndicationsShock, Septic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAttogen Biomedical(Suzhou) Inc Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAttogen Biomedical(Suzhou) Inc Ltd
Active IndicationsN/A
Inactive IndicationsShock, Septic

Other Information

ATC CodeN/A
Related LinksN/A